Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FJ3Q7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,838
Award facts
- Contract value 100% obligated
- $49,837.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product used for cholesterol management. This non-competitive, firm fixed-price delivery order carries a ceiling value of approximately $49.8K and is scheduled for completion by December 2, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary distribution hub for federal pharmaceutical procurement.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $1 billion prime vendor agreement that extends through December 2026 and enables the contractor to supply a broad range of pharmaceuticals and medical supplies to support military healthcare systems globally. As a major pharmaceutical distributor serving federal medical supply chains, AmerisourceBergen maintains an extensive portfolio of delivery orders across therapeutic domains and regularly fulfills competitive federal procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The firm fixed-price structure and expedited completion timeline reflect standard practices for routine pharmaceutical resupply within the DLA Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DR26FJ3Q7?
SPE2DR26FJ3Q7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FJ3Q7 worth?
The government has obligated $49,838 on SPE2DR26FJ3Q7.
Is contract SPE2DR26FJ3Q7 an order under another contract?
Yes. SPE2DR26FJ3Q7 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ3Q7 competed?
The extent of competition for SPE2DR26FJ3Q7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award